SCHM 📈 Schwab U.S. Mid-Cap - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085245087 • Mid-Cap Blend
SCHM: Financials, Industrials, Information Technology, Healthcare, Consumer Discretionary
The Schwab U.S. Mid-Cap ETF, listed on the NYSE ARCA under the ticker symbol SCHM, is designed to track the performance of the Dow Jones U.S. Mid-Cap Total Stock Market Index. This index is a subset of the broader Dow Jones U.S. Total Stock Market Index, focusing specifically on the mid-cap segment of the market. The mid-cap portion is defined as those components ranked 501-1000 by full market capitalization, providing a targeted exposure to this particular market segment. By tracking this index, the ETF offers investors a diversified portfolio of mid-cap stocks, which can be an attractive option for those seeking to tap into the potential of established companies that are still in a growth phase.
The Dow Jones U.S. Mid-Cap Total Stock Market Index is a float-adjusted market capitalization weighted index, meaning that the weights of the components are adjusted to reflect only the publicly available shares, excluding closely held or strategic shares. This approach aims to provide a more accurate representation of the market capitalization available for public investment. The ETF, in turn, will invest at least 90% of its net assets in securities that are included in the index, ensuring a high level of consistency with the underlying index's performance. This investment strategy allows the fund to closely track the index's returns, providing investors with a reliable and efficient way to gain exposure to the U.S. mid-cap market.
As an exchange-traded fund (ETF), the Schwab U.S. Mid-Cap ETF offers the benefits of transparency, flexibility, and cost-efficiency. Listed on the NYSE ARCA, it can be bought and sold throughout the trading day, allowing investors to quickly respond to market opportunities. With its domicile in the United States and ISIN of US8085245087, the fund is subject to U.S. regulatory requirements, providing an additional layer of investor protection. The ETF falls under the mid-cap blend category, indicating that it does not have a specific style bias, such as growth or value, but instead seeks to represent the overall mid-cap market segment. For more information, investors can visit the company's website at http://www.schwabfunds.com.
Additional Sources for SCHM ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SCHM ETF Overview
Market Cap in USD | 11,276m |
Category | Mid-Cap Blend |
TER | 0.04% |
IPO / Inception | 2011-01-13 |
SCHM ETF Ratings
Growth 5y | 62.6% |
Fundamental | - |
Dividend | 53.6% |
Rel. Strength Industry | -24.9 |
Analysts | - |
Fair Price Momentum | 28.74 USD |
Fair Price DCF | - |
SCHM Dividends
Dividend Yield 12m | 2.58% |
Yield on Cost 5y | 4.23% |
Annual Growth 5y | 4.66% |
Payout Consistency | 84.2% |
SCHM Growth Ratios
Growth Correlation 3m | 5.9% |
Growth Correlation 12m | 86.4% |
Growth Correlation 5y | 71.2% |
CAGR 5y | 10.48% |
CAGR/Mean DD 5y | 1.26 |
Sharpe Ratio 12m | 0.97 |
Alpha | -9.22 |
Beta | 1.14 |
Volatility | 17.06% |
Current Volume | 809.7k |
Average Volume 20d | 1115.4k |
As of January 18, 2025, the stock is trading at USD 28.82 with a total of 809,700 shares traded.
Over the past week, the price has changed by +4.34%, over one month by +0.45%, over three months by +2.25% and over the past year by +21.15%.
Yes. Based on ValueRay Analyses, Schwab U.S. Mid-Cap (NYSE ARCA:SCHM) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.59 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCHM as of January 2025 is 28.74. This means that SCHM is currently overvalued and has a potential downside of -0.28%.
Schwab U.S. Mid-Cap has no consensus analysts rating.
According to ValueRays Forecast Model, SCHM Schwab U.S. Mid-Cap will be worth about 32.1 in January 2026. The stock is currently trading at 28.82. This means that the stock has a potential upside of +11.38%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 32.1 | 11.4% |